$193 Million is the total value of Asymmetry Capital Management, L.P.'s 29 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 56.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $12,190,000 | -17.8% | 74,164 | -17.5% | 6.31% | -6.8% |
| PODD | Sell | INSULET CORP | $11,267,000 | -3.4% | 43,183 | -5.4% | 5.83% | +9.6% |
| GH | Sell | GUARDANT HEALTH INC | $9,450,000 | -7.5% | 61,909 | -21.9% | 4.89% | +5.0% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $9,366,000 | -19.0% | 142,530 | -17.5% | 4.84% | -8.1% |
| BDSX | Sell | BIODESIX INC | $9,019,000 | -6.6% | 444,051 | -7.3% | 4.66% | +6.0% |
| KURA | Sell | KURA ONCOLOGY INC | $7,844,000 | -30.7% | 277,468 | -19.9% | 4.06% | -21.4% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $6,641,000 | -26.6% | 236,494 | -32.1% | 3.44% | -16.7% |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCadr | $6,440,000 | +0.9% | 712,371 | -25.5% | 3.33% | +14.4% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $5,962,000 | -62.1% | 79,650 | -56.2% | 3.08% | -57.0% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $3,496,000 | -25.3% | 102,286 | -26.1% | 1.81% | -15.3% |
| FBRX | Sell | FORTE BIOSCIENCES INC | $1,823,000 | -41.1% | 53,197 | -37.4% | 0.94% | -33.2% |
| BLSA | Sell | BCLS ACQUISITION CORP- CL A | $871,000 | -12.3% | 82,377 | -7.6% | 0.45% | -0.4% |
| GLTO | Sell | GALECTO INC | $690,000 | -83.6% | 113,515 | -66.4% | 0.36% | -81.4% |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC. | $0 | – | -46,910 | -100.0% | -0.41% | – |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -80,069 | -100.0% | -0.56% | – |
| WVE | Exit | WAVE LIFE SCIENCES PTE LTD | $0 | – | -280,924 | -100.0% | -1.01% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -67,210 | -100.0% | -1.04% | – |
| NCNA | Exit | NUCANA PLC-ADRadr | $0 | – | -613,769 | -100.0% | -1.26% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -157,583 | -100.0% | -1.56% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB-CVRrts | $0 | – | -5,152,098 | -100.0% | -1.62% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -130,654 | -100.0% | -1.90% | – |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -2,239,803 | -100.0% | -1.98% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -50,709 | -100.0% | -2.10% | – |
| CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -139,343 | -100.0% | -2.10% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTD-ADRadr | $0 | – | -217,728 | -100.0% | -2.29% | – |
| TXG | Exit | 10X GENOMICS INC-CLASS A | $0 | – | -37,587 | -100.0% | -2.43% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -318,492 | -100.0% | -3.17% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -88,195 | -100.0% | -3.53% | – |
| FLDM | Exit | FLUIDIGM CORP | $0 | – | -1,544,904 | -100.0% | -4.23% | – |
| VTRS | Exit | Viatris Inc | $0 | – | -1,130,504 | -100.0% | -9.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.